In the News

Exploring the Tumor Microenvironment in Cancer Treatment

In the News / By walid

Exploring the Tumor Microenvironment in Cancer Treatment Read More »

UChicago spinout Pyxis secures $152 million Series B, signs licensing agreement with Pfizer

In the News / By walid

UChicago spinout Pyxis secures $152 million Series B, signs licensing agreement with Pfizer Read More »

ViewPoints Interview: Pyxis Oncology’s Dr. Lara S. Sullivan and Dr. Ronald Herbst Share Insights on the Importance of Series B Funding to Advance their Portfolio

In the News / By walid

ViewPoints Interview: Pyxis Oncology’s Dr. Lara S. Sullivan and Dr. Ronald Herbst Share Insights on the Importance of Series B Funding to Advance their Portfolio Read More »

Pyxis debuts next-gen cancer ADCs from under Pfizer’s wing

In the News / By walid

Pyxis debuts next-gen cancer ADCs from under Pfizer’s wing Read More »

Other news to note for April 27, 2021

In the News / By walid

Other news to note for April 27, 2021 Read More »

Pyxis unveils ambitions on ADCs

In the News / By walid

Pyxis unveils ambitions on ADCs Read More »

Money on the Move: March 24-30

In the News / By walid

Money on the Move: March 24-30 Read More »

Pyxis follows Pfizer alliance with $152m fundraising for cancer pipeline

In the News / By walid

Pyxis follows Pfizer alliance with $152m fundraising for cancer pipeline Read More »

Pyxis Oncology closes $152M Series B

In the News / By walid

Pyxis Oncology closes $152M Series B Read More »

Pyxis Oncology Raises $152M Series B Round

In the News / By walid

Pyxis Oncology Raises $152M Series B Round Read More »